RESTAURANT BRANDS INTERNATIONAL INC. (QSR): what the price assumes
In the published model solve dated 2026-Q2, anchored at $72.48, RESTAURANT BRANDS INTERNATIONAL INC. (QSR) is priced for -2.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.
Generated: 2026-07-25 · Source: https://boothcheck.com/report/QSR
Headline
| Field | Value |
|---|---|
| Ticker | QSR |
| Company | RESTAURANT BRANDS INTERNATIONAL INC. |
| Current price | $72.49/sh |
| Composition | Supply chain sales 31% / Company restaurant sales 25% / Royalties 21% / Property revenues 9% / Franchise fees and other revenue 2% / Advertising revenues and other services 13% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin (value-band context) | 7.3% |
| Operating margin today | 23.7% |
| Margin compression (value-band) | -16.4pp |
| Implied growth | -2.8% |
| Multiple paid | 18x operating income |
The operating-margin figure is value-band context at year 11: derived from the framework's value band, a separate calculation — not part of the priced-in solve.
Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~7.5pp (computed at the 7% minimum rate; the CAPM rate 6.6% sits below it).
Reconcile: at the x-ray's 9.3% required return this reads ~12.8%/yr; the models below use their own rates.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | -0.60σ |
| cohort percentile (of 213 peers) | 51 |
| implied end-window share | 0% |
Valuation X-Ray
The price is justified by relative-multiple; asset-based/earnings-power land below the price.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.95x | 4 | expensive |
| Earnings | 2.37x | 3 | expensive |
| Relative | 1.01x | 5 | expensive |
| Growth | 1.33x | 4 | expensive |
Families that justify the price: Relative Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.8%); the inversion above states its own rate.
Per-Model Detail (n=16)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $59.45 | 1.22x | yes | FCF base $1.7B, growth 9% (input: historical growth), terminal g 4.0%, WACC 7.8%, 6yr projection |
| DCF Exit Multiple | Growth | $63.09 | 1.15x | yes | Exit EV/EBITDA: 16.2x / 18.2x / 20.2x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $79.16 | 0.92x | yes | P/E 28x (static sector reference · 2026-04), scenarios: 23.4x / 28.0x / 32.6x (bear / base = reference held flat / bull), EV/EBITDA 18x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | $50.52 | 1.43x | yes | Stage 1: 7% for 5yr, Stage 2: 3.5% perpetual |
| Simple Excess Return | Asset | $30.60 | 2.37x | yes | BV/sh $8.15, ROE (TTM) 34.7%, ke 9.3% |
| Two-Stage Excess Return | Asset | $63.15 | 1.15x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $46.71 | 1.55x | yes | Rev $9.6B, growth 9% (input: historical growth; tapered), Terminal P/S: 2.9x / 3.5x / 4.0x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $33.96 | 2.13x | yes | EPS $2.83, growth 7% (input: historical EPS growth), PEG=3.94 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $15.75 | 4.60x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $2.12B × (1−8%) / WACC 7.8% → EPV (no growth) |
| Residual Income | Asset | $47.62 | 1.52x | yes | BV $8.15 + 5yr PV of (ROE (TTM) 34.7% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $22.79 | 3.18x | yes | √(22.5 × EPS $2.83 × BVPS $8.15) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $71.51 | 1.01x | yes | EBITDA $2.68B × sector EV/EBITDA 18.0x |
| FCF Yield | Earnings | $3.21 | 22.58x | yes | FCF $1564.0M / Kₑ 9.3% — zero-growth perpetuity (excluded from median) |
| SBC-Adj FCF Yield | Earnings | $0.01 | 7248.50x | yes | SBC-adj FCF $1.43B (FCF $1.56B − SBC $0.14B) capitalized at Kₑ (excluded from median) |
| Ben Graham Formula | Earnings | $51.02 | 1.42x | yes | EPS $2.83 × (8.5 + 2×6.5%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $3.05 | 23.77x | yes | BV $8.15 × (ROIC 2.9% / WACC 7.8%) (excluded from median) |
| P/Sales Sector | Relative | $94.01 | 0.77x | yes | Revenue $9.59B × sector P/S 4.5x |
| PEG Fair Value | Relative | $27.62 | 2.62x | yes | EPS $2.83 × (PEG 1.5 × growth 6.5% (input: historical EPS growth)) → PE 9.8x |
| Earnings Yield | Earnings | $30.59 | 2.37x | yes | EPS $2.83 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $13.6b |
| Net debt / NOPAT (after-tax) | 6.73x |
| Net debt / operating income (pre-tax) | 6.20x |
| Share count CAGR (dilution) | 0.1% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
At $73.45 the price pays roughly 18 times company-wide operating income, and inverted it asks for essentially no growth at all (about minus 3% a year). For a franchisor targeting 8%-plus organic operating-income growth, the bar the price sets is undemanding.
The single number that frames everything is leverage. Net debt sits near $13.6 billion, close to six times trailing operating income. That is the financial reality behind a thin book value and an asset-light royalty model, and it is what makes the equity a leveraged claim on the brands rather than a clean compounder.
The brand portfolio is mixed but improving at the top. Q1 2026 comparable sales grew 3.2%, with Burger King US up 5.8% and Tim Hortons posting a 20th straight positive quarter, while Popeyes fell 6.5%. Relative and growth methods support the price; the asset and pure earnings-floor methods, distorted by the leveraged structure, do not.
Bull Case
The single most decisive metric here is organic adjusted operating-income growth, because for an asset-light franchisor that one number, more than comparable sales or unit count, drives the cash that services the debt and funds the buyback. In the first quarter of 2026 it ran at about 10.7%, and management reaffirmed it remains on track for 8%-plus organic operating-income growth for the full year. If that holds, the price is cheap: inverted, the $73.45 (June 28, 2026) quote asks for roughly minus 3% operating growth a year, so any positive compounding at all is upside against what the market is paying for.
The operating momentum is real where it matters most. Consolidated system-wide sales grew 6.2% in the first quarter of 2026, with comparable sales accelerating to 3.2%. Burger King US comparable sales surged 5.8%, a sharp reversal from a 1.1% decline a year earlier, and Tim Hortons delivered its 20th consecutive quarter of positive comparable sales. Those are the two largest profit engines in the portfolio, and both are working. The franchised, royalty-based model means that system-sales growth converts to high-margin royalty and supply-chain revenue without the company funding the restaurants directly.
The capital return underlines management's confidence. RBI resumed share repurchases in March 2026 and expects to buy back $500 million during the year. A franchisor that is growing operating income high-single-digits, accelerating comparable sales at its biggest brands, and returning cash, while the price embeds no growth, is the kind of mismatch the bull case is built on. The relative and forward methods agree: relative valuation lands near $79, EV/EBITDA near $72, and two-stage excess return near $63, all in the zip code of the price or above it, supporting the multiple a steady franchisor deserves.
Bear Case
Before any ratio, the qualitative problem is that this is a roll-up of four brands at very different points in their lifecycles, and the weak one is getting weaker fast. Popeyes same-store sales fell 6.5% in the first quarter of 2026, far worse than the roughly 1.5% decline analysts expected. A brand losing customers at that pace is not a rounding error inside a portfolio; it is a drag that the Burger King recovery has to carry, and it raises the question of whether the company's playbook travels across all four banners or only the ones currently in favor. A franchisor's value is the durability of its royalty stream, and a brand in a 6.5% comparable-sales decline is eroding exactly that.
Now the ratio that the qualitative picture points to: leverage. Net debt sits near $13.6 billion, roughly 5.7 times trailing operating income, financed through a term-loan structure whose covenants restrict the company's ability to incur liens, sell assets, pay dividends, and make investments, with pricing tied to a net first-lien leverage grid (FY2024 10-K, accession 0001618756-25-000087). That debt load is the reason the asset-based and earnings-floor methods produce values far below the price (the book-anchored simple excess return near $31, the Graham number near $23): the equity is a thin, levered slice on top of a large fixed claim. In a downturn, or a higher-for-longer rate environment that lifts refinancing costs, the leverage amplifies any operating disappointment.
The price-to-fundamentals disconnect is therefore two-sided. Strip the growth assumption back toward the Popeyes reality, or stress the cost of the $13.6 billion in debt, and the support thins. The price embeds steady franchisor compounding with manageable leverage; the bear case is simply that one of those two pillars, brand durability or balance-sheet headroom, cracks before the other compensates.
Valuation
Inverted, the price is undemanding. At $73.45 RBI trades at roughly 18 times company-wide operating income, which solves to operating growth of about minus 3% a year for five years at a 7% cost of capital (the model floors the rate at 7%, slightly above the CAPM rate). Each one-point change in the cost of capital moves the implied growth rate about 7.5 points. A price that asks for slightly negative growth from a franchisor guiding to 8%-plus organic operating-income growth is the definition of a within-range, even conservative, embedded assumption.
The methods split by family, and the split is structural to the business model. The relative family supports the price: relative valuation near $79, EV/EBITDA near $72. The growth family lands a bit below: perpetual-growth DCF near $59, exit-multiple DCF near $64, discounted-future-market-cap near $47. The asset and pure earnings-floor methods produce values far below: simple excess return near $31, Graham number near $23. Several earnings-floor methods (the zero-growth FCF-yield and ROIC-justified book methods) print near-zero values and should be disregarded; they break down on a highly leveraged, asset-light franchisor where book value and unlevered returns are not meaningful anchors. The blended central estimate that survives the screen is about $59.
The reconciliation: the price is justified by the relative multiple while the asset and earnings-power methods say it looks expensive on a static, leverage-distorted view. The decisive overlay is the balance sheet: net debt near $13.6 billion at about 5.7 times operating income means the equity is a leveraged claim, so the valuation is more sensitive to both operating growth and refinancing cost than the headline multiple suggests.
Catalysts
The most recent catalyst was the first-quarter 2026 report. Consolidated system-wide sales grew 6.2%, comparable sales accelerated to 3.2%, organic adjusted operating income grew about 10.7%, and adjusted EPS grew about 14.6%. Management reaffirmed it remains on track for 8%-plus organic operating-income growth for 2026, the single most important metric for the thesis, so each quarter's read on that figure is the key marker.
The brand-level catalysts cut both ways. Burger King US comparable sales surged 5.8%, reversing a prior-year decline, and Tim Hortons posted its 20th consecutive positive quarter. Against that, Popeyes same-store sales fell 6.5%, well below expectations, so the pace of any Popeyes turnaround is a swing factor worth watching closely. The durability of the Burger King US recovery is the other.
On capital return, RBI resumed share repurchases in March 2026 and expects to buy back $500 million during the year, a positive to track. The overriding risk is the balance sheet: with net debt near $13.6 billion, the cost and timing of refinancing, and any move in interest rates, are catalysts in their own right for a leveraged franchisor.
Sources: RBI Q1 2026 results (rbi.com, Yahoo Finance, kalkine.com, The Motley Fool).
Peer Cohorts (Per Segment, With Filing Citations)
Tim Hortons (TH) (reported)
- SBUX (Starbucks Corporation)
- (no filing in the citation store)
- BROS (DUTCH BROS INC.)
- (no filing in the citation store)
- MCD (McDONALD’S CORPORATION)
- (no filing in the citation store)
- YUM (YUM! BRANDS, INC.)
- (no filing in the citation store)
- WEN (Wendy's Co)
- (no filing in the citation store)
Burger King (BK) (reported)
- MCD (McDONALD’S CORPORATION)
- (no filing in the citation store)
- WEN (Wendy's Co)
- (no filing in the citation store)
- YUM (YUM! BRANDS, INC.)
- (no filing in the citation store)
- SHAK (SHAKE SHACK INC.)
- (no filing in the citation store)
- CAKE (THE CHEESECAKE FACTORY INCORPORATED)
- (no filing in the citation store)
Popeyes Louisiana Kitchen (PLK) (reported)
- WING (WINGSTOP INC.)
- (no filing in the citation store)
- YUM (YUM! BRANDS, INC.)
- (no filing in the citation store)
- CMG (CHIPOTLE MEXICAN GRILL, INC.)
- (no filing in the citation store)
- SHAK (SHAKE SHACK INC.)
- (no filing in the citation store)
Firehouse Subs (FHS) (reported)
- CAVA (CAVA Group, Inc.)
- (no filing in the citation store)
- CMG (CHIPOTLE MEXICAN GRILL, INC.)
- (no filing in the citation store)
- SHAK (SHAKE SHACK INC.)
- (no filing in the citation store)
- WING (WINGSTOP INC.)
- (no filing in the citation store)
Restaurant Holdings (RH) (reported)
- YUM (YUM! BRANDS, INC.)
- (no filing in the citation store)
- MCD (McDONALD’S CORPORATION)
- (no filing in the citation store)
- WEN (Wendy's Co)
- (no filing in the citation store)
- YUMC (Yum China Holdings, Inc.)
- (no filing in the citation store)
- CMG (CHIPOTLE MEXICAN GRILL, INC.)
- (no filing in the citation store)
- SBUX (Starbucks Corporation)
- (no filing in the citation store)
- BROS (DUTCH BROS INC.)
- (no filing in the citation store)
- TXRH (Texas Roadhouse, Inc.)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.